Patent details
91222
Product Name:
"Alendronate Sodium/Colecalciferol et ses dérivés pharmaceutiquement acceptables (FOSAVANCE®)"
Basic Information
- Publication number:
- 91222
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
-
EP989357520
- Legal Status:
- Lapsed
- Application number:
- 91222
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
1
- Marketing Authorization Number:
- EU/1/05/310/001-005
- Marketing Authorization Type:
-
- Marketing Authorization Date:
- 24/08/2005
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
2
- Marketing Authorization Number:
- EU/1/05/310/001-005
- Marketing Authorization Type:
-
- Marketing Authorization Date:
- 24/08/2005
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
-
Dates
- Filing date:
- 15/02/2006
- First Marketing Authorization date:
- 24/08/2005
- Grant date:
- 18/04/2006
- Activation date:
- Publication date:
- 18/04/2006
- Lapsed date:
- 17/07/2018
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 24/08/2020
- SPC Extension Expiration:
- 24/08/2020
- Rejection date:
- Withdrawal date:
Owner
- From:
- 15/02/2006
-
-
- Name:
- MERCK & CO., INC.
- Address:
- EAST LINCOLN AVENUE 126, 07065, RAHWAY, N.J., United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 15/02/2006
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- DAIFOTIS Anastasia, G.
- Address:
- United States (US)
2
- Name:
- SANTORA Arthur, C., II
- Address:
- United States (US)
3
- Name:
- YATES A., John
- Address:
- United States (US)
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-
| Filing date |
Document type |
Number of pages |